logo
SPARC shares drop nearly 20% after key drug trial fails

SPARC shares drop nearly 20% after key drug trial fails

Business Upturn3 days ago

By Aman Shukla Published on June 4, 2025, 11:35 IST
Shares of Sun Pharma Advanced Research Company (SPARC) declined sharply by nearly 20% after the company announced the discontinuation of clinical trials for its experimental drug Vibozilimod (SCD-044). The drop came following an update from Sun Pharmaceutical Industries Limited, SPARC's collaborator, which revealed that the Phase 2 trials for Vibozilimod failed to meet their primary efficacy endpoints.
The drug, which was being tested for treating moderate-to-severe psoriasis and atopic dermatitis, did not show the required 75% improvement in PASI and EASI scores by Week 16. As a result, no further trials will be conducted, marking a significant setback for both companies' specialty drug pipelines.
Shares of Sun Pharma Advanced Research Company (SPARC) opened at ₹185.00 and touched an intraday low of ₹156.14, reflecting a sharp decline. The stock did not move above its opening price, indicating bearish sentiment. SPARC is currently trading closer to its 52-week low of ₹109.30, far below the 52-week high of ₹258.00. As of 11:34 AM, the shares were trading 17.95% lower at Rs 160.15.
Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information.
Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at BusinessUpturn.com

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

UPL's Advanta Brazil to sell Serra Bonita assets for $125 million
UPL's Advanta Brazil to sell Serra Bonita assets for $125 million

Business Upturn

time6 hours ago

  • Business Upturn

UPL's Advanta Brazil to sell Serra Bonita assets for $125 million

Advanta Comércio de Sementes Ltda. ('Advanta Brazil'), a leading global seed company and part of the UPL Group, has announced the sale of all assets of its Brazilian associate company, Serra Bonita Sementes S.A. ('Serra Bonita'), for a total consideration of USD 125 million, subject to closing adjustments. Advanta holds a 33% stake in Serra Bonita. This strategic transaction highlights UPL's focus on optimizing its asset portfolio and unlocking shareholder value. The proceeds from the sale will be received by Serra Bonita and are expected to be fully distributed to its shareholders in the coming months. The sale process will conclude with the legal winding-up of Serra Bonita. Advanta, as part of UPL Group, specializes in the research, development, production, and commercialization of high-performance seeds, with an emphasis on climate-smart crops designed to tackle global climate variability. The company's strengthened collaboration with the Roquetto Group underlines its commitment to sustainable innovation and the promotion of regenerative agriculture practices throughout Brazil. UPL also extended its gratitude to the management, employees, and shareholders of Serra Bonita for their valuable partnership and contributions over the years, reaffirming its dedication to continued shared growth and enhanced strategic alignment. Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at

Stocks hitting 52-week highs today, June 6: SBI Cards, HDFC Bank, Manappuram Finance, Bharat Electronics and more
Stocks hitting 52-week highs today, June 6: SBI Cards, HDFC Bank, Manappuram Finance, Bharat Electronics and more

Business Upturn

time7 hours ago

  • Business Upturn

Stocks hitting 52-week highs today, June 6: SBI Cards, HDFC Bank, Manappuram Finance, Bharat Electronics and more

By Aman Shukla Published on June 6, 2025, 15:53 IST Indian equity markets closed strongly on June 6, 2025, following a surprise monetary easing by the Reserve Bank of India (RBI). The central bank slashed the repo rate by 50 basis points and reduced the Cash Reserve Ratio (CRR) by 100 basis points, boosting investor confidence and lifting market sentiment. The benchmark Sensex surged 746.95 points, or 0.92%, to close at 82,188.99, while the Nifty 50 index crossed the crucial 25,000 mark, rising 252.15 points (1.02%) to settle at 25,003.05. Several prominent stocks touched new 52-week highs today, reflecting strong buying interest amid the positive macroeconomic developments. Here are some key stocks that reached their highest price levels today. Company Market Price (₹) 52-Week High (₹) APL Apollo Tubes 1,920.90 1,924.80 JK Cement 5,876.50 5,900.00 SRF 3,123.50 3,139.00 Manappuram Finance 247.56 248.95 Fortis Healthcare 763.30 767.85 SBI Cards And Payment Services 993.10 999.45 AU Small Finance Bank 749.55 755.50 HDFC Bank 1,978.70 1,996.30 Muthoot Finance 2,446.20 2,470.00 KRBL 372.30 376.00 Maharashtra Scooters 14,303.00 14,482.00 Fiem Industries 1,881.20 1,906.00 HDFC Asset Management Company 5,087.50 5,157.80 LT Foods 477.35 483.95 Multi Commodity Exchange of India 7,418.00 7,531.00 Bharat Electronics 390.70 396.85 Shree Global Tradefin Ltd. 70.33 71.50 BSE 2,933.20 2,985.00 Abbott India 31,630.00 32,200.00 Godrej Industries 1,359.50 1,390.00 Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information. Bharat ElectronicsHDFC BankManappuram FinanceSBI CardsStock Market Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at

NTPC's subsidiary THDC India starts commercial operation of 250 MW Tehri PSP unit
NTPC's subsidiary THDC India starts commercial operation of 250 MW Tehri PSP unit

Business Upturn

time7 hours ago

  • Business Upturn

NTPC's subsidiary THDC India starts commercial operation of 250 MW Tehri PSP unit

NTPC Limited has announced that the first unit of the Tehri Pumped Storage Plant (PSP) of THDC India Limited, its subsidiary, has commenced commercial operation. The unit, with a capacity of 250 MW, started operations effective from 00:00 hours on June 7, 2025. The Tehri PSP project consists of four units, each with 250 MW capacity, totaling 1,000 MW. With this unit now operational, NTPC Group's total installed and commercial power generation capacity increases to 80,515 MW. In the excahgne filingm teh copmany shared, 'In terms of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that First Unit of 250 MW of Tehri PSP (4×250 MW) of THDC India Limited, a subsidiary of NTPC Limited, is declared on Commercial Operation w.e.f. 00:00 Hrs of 07.06.2025.' In the meantime, today, NTPC Green Energy Limited has declared 110.25 MW of the 1,255 MW Khavda-I Solar PV Project in Gujarat commercially operational as of June 6, 2025. The project is developed by NTPC Renewable Energy Limited, a wholly owned subsidiary of NTPC Green Energy. Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store